Page 3 - Memory Centre News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rencontrez les membres de l'équipe du Pôle Santé Social

Alzheimer's disease, one of the most common neurodegenerative diseases, leads to progressive loss of memory and autonomy.

Alzheimer’s disease, one of the most common neurodegenerative diseases, leads to progressive loss of memory and autonomy. It is characterised by the accumulation of neurotoxic proteins in the brain, namely amyloid plaques and tau tangles. Due to the silent development of pathology over decades, very early diagnosis is of utmost importance to be able to take action as early as possible in the disease process. A team from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) has demonstrated that tau PET - a novel imaging technique for visualising the tau protein - can pre...

After months of anticipation, US Food and Drug administration has finally granted traditional approval to lecemab, a drug that's been shown to significantly slow the progression of Alzheimer's.

(CTN NEWS) - The Food and Drug Administration (FDA) has endorsed the intravenous (IV) drug Leqembi for patients with mild dementia and early Alzheimer's